Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P4HA1 | P13674 | 3/20 | 0.61 |
| ▸ | P4HTM | Q9NXG6 | 2/20 | 0.61 |
| ▸ | MIF | P14174 | 1/20 | 0.59 |
| ▸ | GABRP | O00591 | 1/20 | 0.57 |
| ▸ | GABRD | O14764 | 1/20 | 0.57 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.57 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.57 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.57 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.57 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.57 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.57 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.57 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.57 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.57 |
| ▸ | GABRE | P78334 | 1/20 | 0.57 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.57 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.57 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.57 |
| ▸ | GABRQ | Q9UN88 | 1/20 | 0.57 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29723813 | 1.00 | P4HA1 (0.61) | P4HA1P4HTMMIFGABRPGABRD | |
| SCHEMBL29646483 | 1.00 | P4HA1 (0.61) | P4HA1P4HTMMIFGABRPGABRD | |
| SCHEMBL30448953 | 1.00 | P4HA1 (0.61) | P4HA1P4HTMMIFGABRPGABRD | |
| Hydrochloric Acid SCHEMBL698501 | 0.98 | P4HA1 (0.59) | P4HA1P4HTMMIFGABRPGABRD | |
| SCHEMBL27594193 | 0.84 | RXFP1 (0.53) | P4HA1P4HTMMIFGABRPGABRD | |
| SCHEMBL2042090 | 0.84 | BCL2L1 (0.59) | HSD17B10TP53TSHRBCL2L1BAD | |
| SCHEMBL29788190 | 0.84 | BCL2L1 (0.59) | HSD17B10TP53TSHRBCL2L1BAD | |
| SCHEMBL691934 | 0.80 | NAPRT (0.45) | P4HA1P4HTMMIFGABRPGABRD | |
| SCHEMBL18910409 | 0.80 | KCNQ3 (0.44) | P4HA1P4HTMMIFGABRPGABRD | |
| SCHEMBL2514243 | 0.80 | KCNQ3 (0.44) | P4HA1P4HTMMIFGABRPGABRD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 735 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119823035-A | Preparation method of m-aminobenzoic acid bisamide compound | 湖南化工研究院有限公司 | 2025-04-15 | — | — | CN | claimed |
| CN-119823033-A | Synthesis method of 2-fluoropyridine-5-formyl chloride | 湖南化工研究院有限公司 | 2025-04-15 | — | — | CN | claimed |
| WO-2024245356-A1 | M-AMIDOBENZOIC ACID BISAMIDE COMPOUND AND INTERMEDIATE THEREOF | 湖南化工研究院有限公司 | 2024-12-05 | — | — | WO | claimed |
| EP-4008718-B1 | HETEROARYLAMIDOPYRIDINOL DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASE | INNOVO THERAPEUTICS INC (KR) | 2024-10-30 | — | — | EP | claimed |
| CN-115433122-B | Preparation method of 6-fluoro nicotinic acid | 大连双硼医药化工有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-116987064-B | Preparation method and application of pyrimidine bisnicotinamide derivative | 宁夏佰斯特医药化工有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-116987064-A | Preparation method and application of pyrimidine bisnicotinamide derivative | 宁夏佰斯特医药化工有限公司 | 2023-11-03 | — | — | CN | claimed |
| CN-115869923-A | Oxygen absorbing material, preparation method thereof and prepared adsorbing material capable of adsorbing oxygen and organic solvent simultaneously | 威格科技(苏州)股份有限公司 | 2023-03-31 | — | — | CN | claimed |
| CN-113912592-B | Honokiol dihydrofuran ester derivative, preparation method and application thereof | 西北农林科技大学 | 2023-03-10 | — | — | CN | claimed |
| CN-115433122-A | Preparation method of 6-fluoronicotinic acid | 大连双硼医药化工有限公司 | 2022-12-06 | — | — | CN | claimed |
| CN-115260176-A | Pyrazole amide derivative containing oxazole group and preparation method and application thereof | 安徽农业大学 | 2022-11-01 | — | — | CN | claimed |
| CN-113046734-A | Bivalent palladium complex solution and preparation method and application thereof | 上海天承化学有限公司 | 2021-06-29 | — | — | CN | claimed |
| CN-120590466-B | Compound of targeted fibroblast activation protein and application thereof | 首都医科大学脑重大疾病研究中心(北京脑重大疾病研究院) | 2026-05-12 | — | — | CN | disclosed |
| CN-121824416-A | Method for preparing 6-fluoronicotinic acid based on heterogeneous catalytic system | 苏州艾缇克药物化学有限公司 | 2026-04-10 | — | — | CN | disclosed |
| CN-121824416-A | Method for preparing 6-fluoronicotinic acid based on heterogeneous catalytic system | 苏州艾缇克药物化学有限公司 | 2026-04-10 | — | — | CN | disclosed |
| US-20260091148-A1 | DIAGNOSTIC PET IMAGING OF CARDIAC AMYLOIDOSIS | Higuchi, Takahiro (DE) | 2026-04-02 | — | — | US | disclosed |
| US-4358455-A | GLAUCOMA, HYPOTENSIVE, ANTIARRHYTHMIA, BRONCHODILATORS | MERCK & CO., INC. (US) | 1982-11-09 | — | — | US | disclosed |
| US-4046768-A | 1-Thiazolyl-5-pyridylcarbonyloxyimidazolidinones | VELSICOL CHEMICAL CORPORATION (US) | 1977-09-06 | — | — | US | disclosed |
| US-4045446-A | 1-Benzothiazolyl-5-pyridylcarbonyloxyimidazolidinones | VELSICOL CHEMICAL CORPORATION (US) | 1977-08-30 | — | — | US | disclosed |
| US-4033753-A | HERICIDES | VELSICOL CHEMICAL CORPORATION (US) | 1977-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091148-A1 | DIAGNOSTIC PET IMAGING OF CARDIAC AMYLOIDOSIS | TNNC1, TNNT2, TNNI3 | P4HA1 1565/4885P4HTM 3740/4885MIF 4759/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.